. Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial. J Psychopharmacol. 2019 Aug;33(8):1030-1033. Epub 2019 May 22 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.